Our recent findings revealed that, in Ph+ leukemia cells, the Lys residues in BCR-ABL are modified by a scaffolding protein RAPSYN that possesses NEDD8 E3 ligase activity[8]. The gene discussed is RAPSN; the disease is leukemia.